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Amylin as a growth factor during fetal and postnatal development of
the rat kidney. We have previously reported that amylin has mitogenic
actions on tubular epithelial cells isolated from mature rat kidney and
cultured in vitro. In experiments using in situ hybridization, we have
demonstrated that amylin mRNA can be detected transiently in rat
metanephros from embryo day 17 (E17) to postnatal day 3 (PN3). These
transcripts are localized in the sub-nephrogenic zone. RT-PCR was
performed using oligonucleotide primers for rat amylin and mRNA
extracted from fetal body (E19), PN1 and PN5 metanephroi, and adult rat
kidney. These results corroborate the finding, using in situ hybridization,
that there is a window of expression of rat amylin in the developing kidney
in the perinatal period. During this period tubular elongation is evident
and amylin peptide, detected by immunohistochemical staining, is found
associated with developing tubules. Some of these tubules also express a
brush border glycoprotein, detected by immunohistochemical staining.
Amylin acts as a mitogen with primary cultures of proximal tubular
epithelial cells from PN4 renal cortex. An amylin antagonist inhibited this
mitogenic action suggesting that this was mediated by amylin receptors as
previously described. We suggest that amylin peptide is biosynthesized in
the developing proximal tubules, acts in an autocrine fashion to promote
the proliferation and differentiation of brush border epithelial cells and
hence plays an important role as a growth factor in the development of the
kidney.
Amylin is a 37-amino acid polypeptide [1, 2] that is cosecreted
with insulin [3, 4] from pancreatic b-cells. We have recently
proposed that amylin is an important hormone with novel func-
tions in renal physiology [5–7], although it is also thought to be an
endocrine regulator of carbohydrate [8–10] and bone metabolism
[11, 12]. Furthermore, it has been postulated that this hormone is
implicated in insulin resistant states [13–15] such as non-insulin-
dependent diabetes mellitus (NIDDM).
The involvement of amylin with functions principally within the
proximal tubules in the adult rat kidney is based on five key
findings. Firstly, we have identified high-affinity amylin binding
sites in renal cortex that can be distinguished from those of the
homologs, calcitonin and calcitonin gene-related peptide, on the
basis of regional distribution in kidney tissue sections, and phar-
macological characterization of the binding site with peptide
antagonists [7]. The inhibition of [125I]-amylin binding by the
hydrolysis-resistant nucleotide, GTPgS, suggested the receptor is
a member of that superfamily coupled to G-proteins [7]. Secondly,
in vivo experimentation demonstrated that amylin bound to
proximal tubules rather than distal tubules, collecting ducts,
interstitium or glomeruli [6]. Thirdly, when administered to
human volunteers [16, 17] or rats [7, 17], amylin stimulated
plasma renin activity five- and twofold, respectively. Fourthly, in
micropuncture experiments, amylin was a potent stimulant of
sodium/water reabsorption, mediated by the Na1/H1 exchanger
of the proximal tubules [6]. Finally, in vitro, amylin acts as a
mitogen to stimulate hyperplasia in primary cultures of epithelia
of the proximal tubules isolated from adult kidneys [6]. Others
have noted that amylin may act as a growth promoter for human
umbilical vein endothelial cells [18] and osteoblasts [12].
Here we explore the role of amylin as a growth factor in the
tubules of the fetal and postnatal metanephros.
METHODS
The handling of animals and the surgical procedures were in
accordance with the guidelines set down by the NHMRC in
Australia. In this study timed matings using Sprague-Dawley rats
were performed. Pregnant animals were anesthetized with 60
mg/kg (i.p.) pentabarbitone before surgical removal of the fetuses
at specified dates.
In situ hybridization to detect localized mRNA
Single-stranded RNA probes were prepared from partial cDNA
clones for amylin. The antisense probes were labeled with [33P]-
UTP (NEN, Dupont) using SP6 RNA polymerase (Boehringer
Mannheim, Germany) to produce an amylin probe of 0.51 kb in
length. These probes were hybridized to 4% paraformaldehyde-
fixed, paraffin-embedded sections [19] overnight at 55°C. Post-
hybridization washes were carried out in 50% formamide buffer at
55°C, followed by RNase A (150 mg/ml at 37°C) and sections were
then dehydrated and autoradiographed using Ilford K5 emulsion
(Ilford, Cheshire, UK). The negative control was made by labeling
the sense strand for amylin using [33P]-UTP and T3 RNA
polymerase (Boehringer Mannheim, Germany). This probe was
then used to hybridize negative control sections under identical
conditions to those used with the antisense probes. Autoradio-
graphs were developed using D19 developer (Kodak, Rochester,
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NY, USA) and photographed using an Olympus BX50 micro-
scope.
Reverse transcription-polymerase chain reaction from total
RNA
The reverse transcriptase reaction was carried out using stan-
dard techniques with total RNA extracted from fetal bodies,
postnatal metanephroi and adult rat kidney. An aliquot of the
resulting cDNA was used in the PCR reaction and 30 ml of a
master mix reaction contained rat amylin primers, dNTPs, PCR
buffer and the Taq enzyme. The PCR reaction was run for 40
continuous cycles. The sequences of oligonucleotides used as the
59-primer and 39-primer for the amplification of the rat amylin
PCR product were (59-.39) CCTGTCGGAAGTGGTACC and
ACGGGAGTACATTGACT, respectively. This was predicted to
produce a PCR product of 227 base pairs.
Quantitation of the band intensity was performed on a Bio-Rad
Gel Doc system using the software Microsoft Analyst.
Preparation of the amylin polyclonal antibody
Antibodies to rat amylin amide were raised in four New
Zealand white rabbits immunized at three-week intervals over a
period of seven months. The immunogen was prepared by a
modification of the method of Butler et al [20]. Rat amylin amide
(5 mg) and 25 mg bovine thyroglobulin (Sigma, St. Louis, MO,
USA) were reacted with 5 mg ethylcarbodiamide in 4 ml of 10 mM
phosphate buffered saline pH 7.5 at 4°C for 24 hours. Trace
amounts of [125I]-amylin added into the reaction revealed less
than 5% conjugation by Sephadex G75 gel filtration. Addition of
40 ml glutaraldehyde and a further 72 hours at 4°C resulted in over
80% conjugation. Gel filtration was used to purify the rest of the
conjugated material over four column runs, pooled and stored in
aliquots for 10 injections. The first immunization was prepared
with equal volumes of Freund’s complete adjuvant. Subsequent
immunizations used incomplete adjuvant. All rabbits produced
high titers of antibody but with low affinities.
Immunohistochemical staining
Immunohistochemical staining for amylin was performed using
the rabbit polyclonal anti-rat amylin antibody, described above, at
a concentration of 1:2,500. Specificity was tested by pre-absorp-
tion of the antibody with an excess of purified rat amylin peptide,
which abolished specific amylin staining. Four-micron paraffin
sections were prepared from 4% paraformaldehyde fixed, paraffin
Fig. 2. RT-PCR products of amylin (even numbered tracks), histone (odd
numbered tracks) and 100 base pair ladder (tracks 1 & 10), separated on
a 2% agarose gel. The pairs of tracks 2 & 3, 4 & 5, 6 & 7 and 8 & 9 are
derived from E19 body, PN1 metanephroi, PN5 metanephroi and adult
kidney, respectively.
Fig. 3. Serial sections from an E18 metanephros indicating (A) immu-
nohistochemical staining using the polyclonal antibody against amylin
peptide associated with tubules (bright field, magnification 3260), and
(B) staining with the lectin PHA-E against a brush border glycoprotein
(bright field, 3260). Reproduction of this figure in color was made
possible by a grant from Amlyn Pharmaceuticals, San Diego, CA, USA.
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Fig. 1. Pancreas and metanephros from embryonic day 18 (E18) rat fetus and PN1 metanephros in which amylin mRNA transcripts and amylin
peptide were detected by in situ hybridization using an antisense [33P]-riboprobe and immunohistochemisty, respectively. (A) E18 rat pancreas, amylin
mRNA, bright field (magnification 350). (B) E18 rat pancreas, amylin peptide, bright field (3520); (C) E18 rat metanephros, amylin mRNA, bright
field (times]130); (D) E18 rat metanephros, amylin mRNA, dark field (3130); (E) E18 rat metanephros, amylin mRNA, bright field (3520), arrows
indicate concentrations of silver grains; (F) another field from E18 metanephros showing silver grains associated with tubular cells close to a glomerulus
(g) (3520); (G) another field from E18 rat metanephros, amylin mRNA, bright field (3520), arrows indicate concentrations of silver grains; and (H)
postnatal day 1 metanephros, bright field (3520), arrows indicate concentrations of silver grains. Reproduction of this figure in color was made possible
by a grant from Amlyn Pharmaceuticals, San Diego, CA, USA.
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embedded tissue. Sections were de-waxed and hydrated, and then
endogenous peroxidase was quenched using 0.3% H2O2 in meth-
anol. Antibody was applied at room temperature for one hour.
After washing in phosphate-buffered saline, specific staining was
detected using standard ABC methods [21]. Briefly, slides were
incubated in secondary antibody (biotin conjugated goat anti-
rabbit IgG; Vector Laboratories, Burlingame, USA) at a concen-
tration of 1:200. The avidin-biotin horseradish peroxidase conju-
gate was then applied at a concentration of 1:200 for 15 minutes.
After thorough washing, the final detection step was carried out
using 3,39-diaminobenzidine (Sigma) as chromagen.
Immunohistochemical staining with the lectin, PHA-E
Identification of proximal tubules was carried out by histochem-
ical staining with peroxidase conjugated Phaseolus vulgaris lectin,
PHA-E (Sigma) [22]. Briefly, the peroxidase conjugated lectin was
applied to de-waxed sections after quenching of endogenous
peroxidase activity. The concentration of lectin used was 1 mg/ml.
Staining was detected using standard ABC methods as described
above.
Primary cell cultures
Primary cell cultures of renal proximal tubular cells were
prepared according to methods previously described [6, 23, 24].
Briefly, at least four PN4 Sprague-Dawley pups were anesthetized
with pentobarbitone sodium (6 mg/100 g body wt, intraperitone-
ally), the kidneys immediately removed as aseptically as practica-
ble, placed on ice in Krebs-Henseleit solution (KHS, [24]).
Processing of the kidneys involved decapsulation, dissection of the
cortex, mincing, washing by centrifugation and digestion with
collagenase (Worthington, class II). Homogeneous populations of
nephron segments were separated by centrifugation to establish a
Percoll gradient and resulted in four distinct bands. The lowest
was enriched with proximal tubular fragments. Further details of
methods are described elsewhere [24]. After the initial plating,
antibiotics were no longer used and media not changed until day
3 to allow cell attachment. On day 6, medium was changed to basic
medium alone for controls, plus additions as indicated in Figure 4.
Serum-free, hormone-supplemented (defined medium) or hor-
mone-free culture medium (basic medium) was as previously
described [23, 24]. [3H]-thymidine uptake was determined at day
7 when the cells were observed to be subconfluent. A total of 4
ml/ml medium of [methyl-3H]-thymidine (185 MBq/ml; Amer-
sham) was added and the cells incubated for 16 hours. The cells
were detached with 0.05% trypsin. To determine [3H]-thymidine
incorporation, aliquots of cells were harvested and counted.
Estimation of protein content per cell, an indicator of cell size or
hypertrophy, was determined using the Bio-Rad microassay pro-
cedure. Cell numbers were determined using a hemocytometer.
Peptides
The peptide antagonist of amylin binding, AC512, N-alpha-
acetyl-[K(11)-,R(18)-,N(30)-,Y(32)]-salmon calcitonin (9–32),
has the amino acid sequence, N(Ac)-LGKLSQELHRLQTYPRT-
NTGSNTY-NH2, and was provided by Amylin Pharmaceuticals
Incorporated (La Jolla, CA, USA). Like a similar peptide, AC413,
it has an IC50 for [
125I]-amylin binding in the nanomolar range [6,
7].
RESULTS
The detection of amylin mRNA and peptide by in situ hybrid-
ization and immunohistochemistry are displayed in Figure 1. As a
positive control for these techniques and reagents, they were
tested on sections of rat pancreas. In Figure 1 A and B, amylin
mRNA and peptide were found associated with the islets. The
sense strand of the amylin riboprobe was also tested but no
concentration of silver grains was observed above the background
in either pancreatic or metanephric tissue (data not shown).
Furthermore, the specificity of the rabbit polyclonal anti-rat
amylin antibody was checked by coincubation with 10 mg/ml
amylin prior to immunohistochemical testing on pancreatic tissue,
which resulted in abolition of the color development over the
islets (data not shown).
Within the subnephrogenic zone amylin transcripts can be
detected (bright field Fig. 1C, dark field Fig. 1D). The amylin
transcripts were associated with tubules adjacent to primitive
glomeruli (g), as detected by the presence of silver grains, shown
here under higher magnification (3520, Fig. 1 E, F, G). These
amylin mRNA transcripts were evident in the metanephroi of
postnatal pups (PN1; Fig. 1H), but with less frequency in PN3 and
were undetectable in PN7 kidneys (data not shown).
RT-PCR was performed on total mRNA extracted from the
bodies (including pancreas, metanephros and gut) of E19 rat
fetuses (N 5 4), PN1 (N 5 4) and PN5 (N 5 4) metanephroi, and
adult kidney (N 5 3). Oligonucleotide primers specific for rat
pancreatic amylin were designed to synthesize a PCR product of
227 base pairs in length. In Figure 2, even numbered tracks show
that this PCR product runs as expected [E19 fetus (track 2), PN1
metanephros (track 4), PN5 metanephros (track 6) and adult
kidney (track 8)]. Odd numbered tracks represent RT-PCR
products generated with specific primers for the house-keeping
histone mRNA, for comparison. Quantitation of the density of the
bands from Figure 2 using the software program Microsoft
Analyst, revealed that the intensity of each amylin band relative to
its histone pair (100%) was 50%, 82%, ,1% and ,1%, respec-
tively. Thus, by this analysis amylin mRNA would be expected to
be expressed and up-regulated in the E19 fetus, more highly
expressed in the PN1 metanephros, and considerably down-
regulated in the PN5 metanephros and adult kidney.
Figure 3A shows metanephric tubules in the sub-nephrogenic
region that stain positively with the rabbit anti-rat amylin poly-
clonal antibody and in many instances also stain positively with the
lectin PHA-E (Fig. 3B). The lectin PHA-E is an indicator of the
presence of a glycoprotein on the brush border of tubular
epithelial cells [22, 25]. Some tubules in these serial sections,
indicated by arrows, which stain with the antibody for amylin (Fig.
3A), do not appear to stain positively with PHA-E (Fig. 3B).
The potential of amylin to act as a mitogen, is further suggested
by results shown in Figure 4. Amylin added to primary cultures of
proximal epithelial cells from postnatal day 4 (PN 4) kidneys,
stimulated the proliferation of these cells. Furthermore, this
stimulation was inhibited by the amylin binding site antagonist,
AC512.
DISCUSSION
Amylin mRNA transcripts (Fig. 1A) and peptide (Fig. 1B) were
found in the pancreas of E18 rat fetus, which is coincident with the
major site of synthesis in the adult [3, 4]. However, in this paper
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we report that amylin mRNA is transiently expressed in the
developing metanephros.
Nephrogenesis is a two stage process with reciprocal induction
between the surrounding metanephric mesenchyme (MM) and
epithelium of the ureteric ducts [26–28] that results in a mesen-
chymal to epithelial transition of MM and branching of ureteric
ducts. S- and comma-shaped condensations of these epithelial
cells appear in the outer nephrogenic layer of the expanding
metanephros and mark the beginning of nephrogenesis. These
early events are thought to be mediated by soluble epigenetic
growth factors such as hepatocyte growth factor [29]. A second
stage is marked by events such as the rapid division of tubular
epithelial cells and angiogenesis in the glomerular tuft, events
which take place in the sub-nephrogenic zone. The growth factor
VEGF [30, 31] and its receptor NYK [32–34] are thought to be
essential components of this latter process.
Here we present evidence for the hypothesis that amylin is an
important factor for the growth and development of proximal
tubular epithelial cells. Transcripts which hybridize with an amylin
riboprobe under conditions of high stringency, are localized to
tubules in the vicinity of primitive glomeruli in E18 fetuses (Fig. 1
E, F, G) in the sub-nephrogenic zone (Fig. 1 C, D). The
expression of this mRNA for amylin can be detected around E17
and is associated with the elongating tubules of the metanephros
in the PN1 rat pup (Fig. 1H). By PN3 the density of silver grains
apppears to decrease and has disappeared by PN7 (data not
shown). In Figure 2 the results of experiments using RT-PCR with
specific primers for rat pancreatic amylin demonstrated that
relative to the PCR product of the housekeeping mRNA histone,
amylin mRNA was highly expressed in the PN1 metanephros and
down-regulated in the PN5 metanephros and adult kidney. The
results of the RT-PCR experiments corroborate those described
and obtained by in situ hybridization. Thus, it would seem that
renal transcription of amylin mRNA is down-regulated by molec-
ular events that are as yet undefined. This down-regulation could
perhaps result from changes in the local oxygen tension following
the establishment of the renal peritubular circulation, an event
that would coincide with the availability of amylin from the serum
to the dividing and differentiating tubular cells.
In the E18 fetus we have identified the amylin peptide also
associated with tubules in the sub-nephrogenic zone (Fig. 3A).
Many of these tubules also stain positively (Fig. 3B) with the lectin
PHA-E that stains for a glycoprotein found in the brush border
epithelial cells of proximal tubules [22, 25]. The induction of brush
border antigens of the proximal tubule have previously been
described in the developing mouse metanephros [35]. We have
found that the brush border marker, alkaline phosphatase, is not
apparent in the E18 metanephros but is detectible in the lung and
cartilage (data not shown). However, alkaline phosphatase is
detectible in proximal tubules of adult kidney (data not shown).
We therefore suggest that the expression of amylin is an early
event in tubulogenesis, preceding the expression of the glycopro-
tein (lectin positive) and alkaline phosphatase.
Some glomeruli (Fig. 3A) also appear to stain positively for
amylin and this is most likely derived from serum as the glomer-
ular vasculature appears to be established in many cases. Data
using in situ hybridization and riboprobes for VEGF and its
receptor NYK (data not shown), clearly indicate that the glomer-
ular vasculature but not the peritubular vasculature, is established
at this time.
A role for amylin as a proliferative factor for tubular epithelial
cells is suggested by the results of experiments illustrated in
Figure 4. Here we show that amylin promotes the proliferation of
primary cultures of tubular epithelial cells isolated from PN4
metanephros. These results are similar to those reported by us
previously using cells isolated from adult kidney [6]. The efficacy
of amylin in this assay (Fig. 4) may indicate that amylin acts in
concert with other growth factors. Several growth factors (EGF,
HGF and TGF-a) have been implicated in the development of the
metanephros in general and in the development of the tubules in
particular [36, 37]. It is possible that amylin associated with
precursor epithelial cells promotes other processes such as differ-
entiation, as well as proliferation, since a few tubules at E18 that
stain positively for amylin do not stain for the brush border
glycoprotein (indicated with arrows in Fig. 3).
The location of receptors for and actions of amylin in the
developing proximal tubules is consistent with our previous de-
scription of these events in the adult rat [6]. However, in this latter
case the type of receptor involved appears to be one of the
G-protein coupled class [7]. Most likely, the signaling pathway
that is activated by amylin and its receptors in this instance
involves the MAP kinases, as has been described for some other
G-protein coupled receptors.
The potential importance of these observations in relation to a
role for amylin as a growth factor is not only relevant to our
understanding of the mechanisms of tubular growth and differen-
tiation, but may also have implications for the course of various
renal diseases [5, 25].
Fig. 4. Amylin-induced hyperplasia measured by [3H]-thymidine incor-
poration and corrected for hypertrophy in primary cultures of rat
proximal tubular epithelial cells isolated from PN4 kidney. Also shown is
the response to a maximally effective concentration of epidermal growth
factor (EGF, 25 ng/ml), amylin at different concentrations, 1025 M AC512
and 1027 M amylin plus AC512. Values are means 6 SEM. *P , 0.05,
***P , 0.001 versus control, †††P , 0.001 versus 1027 M amylin (Fisher
PLSD). Numbers in parentheses refer to the number of experiments.
Wookey et al: Amylin as a renal growth factor 29
ACKNOWLEDGMENTS
We acknowledge the support in 1996 of the Australian Kidney Foun-
dation and Sir Edward Dunlop Foundation of Australia. The rat amylin
cDNA was a gift from Dr. Keith Albrandt of Amylin Pharmaceuticals
Incorporated (API), and the antagonist, AC512, was supplied by API, San
Diego, California, USA. We wish to thank Ms. Teresa Bisucci for help
with the establishment of the in situ hybridization and immunohistichem-
istry, and Mr. Julian Oldmeadow and Ms. Leanne Thomas for technical
assistance. We also wish to thank Amlyn Pharmaceuticals, Inc., for a grant
to produce Figures 1 and 3 in color.
Reprint requests to Dr. Peter J. Wookey, Department of Medicine, Univer-
sity of Melbourne, Austin & Repatriation Medical Centre (Repatriation
Campus), Heidelberg West, Victoria 3081, Australia.
E-mail: wookey@austin.unimelb.edu.au
REFERENCES
1. COOPER GJS, WILLIS AC, CLARK A, TURNER RC, SIM RB, REID
KBM: Purification and characterization of a peptide from amyloid
rich pancreases of type 2 diabetic patients. Proc Nat Acad Sci USA
84:8628–8632, 1987
2. WESTERMARK P, WERNSTEDT C, WILANDER E, HAYDEN DW, O’BRIEN
TD, JOHNSON KH: Amyloid fibrils in human insulinoma and islets of
Langerhans of the diabetic cat are derived from neuropeptide-like
protein also present in normal islet cells. Proc Nat Acad Sci USA
84:3881–3885, 1987
3. KAHN SE, D’ALESSIO DA, SCHWARTZ MW, FUJIMOTO WY, ENSINCK
JW, TABORSKY JGJ, PORTE JD: Evidence of cosecretion of islet
amyloid polypeptide and insulin by beta-cells. Diabetes 39:634–638,
1990
4. JOHNSON KH, O’BRIEN TD, HAYDEN DW, JORDAN K, GHOBRIAL
HKG, MAHONEY WC, WESTERMARK P: Immunolocalization of islet
amyloid polypeptide (IAPP) in pancreatic beta cells by means of
peroxidase-antiperoxidase (PAP) and protein-A gold techniques.
Am J Pathol 130:1–8, 1988
5. COOPER ME, WOOKEY PJ: Amylin–Its role in the kidney. Nephrol Dial
Transplant 12:8–10, 1997
6. HARRIS PJ, COOPER ME, HIRANYACHATTADA S, BERKA JL, KELLY DJ,
NOBES M, WOOKEY PJ: Amylin stimulates proximal tubular sodium
transport and cell proliferation in the rat kidney. Am J Physiol
272:F13–F21, 1997
7. WOOKEY PJ, TIKELLIS C, DU H-C, QIN H-F, SEXTON PM, COOPER
ME: Amylin binding in rat renal cortex, stimulation of adenylyl cyclase
and activation of plasma renin. Am J Physiol 270:F289–F294, 1996
8. YOUNG AA: Amylin regulation of fuel metabolism. J Cell Biochem
55:12–18, 1994
9. DEEMS RO, DEACON RW, YOUNG DA: Amylin activates glycogen
phosphorylase and inactivates glycogen synthase via a cAMP-indepen-
dent mechanism. Biochem Biophys Res Commun 174:716–720, 1991
10. COOPER GJ: Amylin compared with calcitonin gene-related peptide:
Structure, biology, and relevance to metabolic disease. Endocrine Rev
15:163–201, 1994
11. MACINTYRE I: Amylin-amide, bone conservation and pancreatic b-
cells. Lancet ii:1026–1027, 1989
12. CORNISH J, CALLON KE, COOPER GJ, REID IR: Amylin stimulates
osteoblast proliferation and increases mineralised bone volume in
adult mice. Biochem Biophys Res Commun 207:133–139, 1995
13. FRONTONI S, CHOI SB, BANDUCH D, ROSSETTI L: In vivo insulin
resistance induced by amylin primarily through inhibition of insulin-
stimulated glycogen synthesis in skeletal muscle. Diabetes 40:568–573,
1991
14. KAUTZKY-WILLER A, THOMASETH K, PACINI G, CLODI M, LUDVIK B,
STRELI C, WALDHAUSL W, PRAGER R: Role of islet amyloid polypep-
tide secretion in insulin-resistant humans. Diabetologia 37:188–194,
1994
15. WILLIAMS B: Insulin resistance: The shape of things to come. Lancet
344:521–524, 1994
16. COOPER ME, MCNALLY PG, PHILLIPS PA, JOHNSTON CI: Amylin
stimulates plasma renin concentration in humans. Hypertension 26:
460–464, 1995
17. YOUNG AA, NUTTALL A, MOYSES C, PERCY A, VINE W, RINK T:
Amylin stimulates the renin-angiotensin-aldosterone axis in rats and
man. (abstract) Diabetologia 38(Suppl 1):A225, 1995
18. DATTA H, RAFTER P, CHEN Z, WIMALAWANSA S, MACINTYRE I:
Amylin-amide displays a proliferative effect on human umbilical vein
endothelial cells. Biochem Soc Transplant 18:1276, 1990
19. DARBY IA, EVANS BA, FU P, LIN GB, MORITZ KM, WINTOUR EM:
Erythropoietin gene expression in fetal and adult sheep kidney. Brit J
Haematol 89:266–270, 1995
20. BUTLER PC, CHOU J, CARTER WB, WANG YN, BU BH, CHANG D,
CHANG JK, RIZZA RA: Effects of meal ingestion on plasma amylin
concentration in NIDDM and nondiabetic humans. Diabetes 39:752–
756, 1990
21. HSU SM, RAINE L, FANGER H: Use of avidin-biotin peroxidase
complex (ABC) in immunoperoxidase technique: A comparison be-
tween ABC and unlabelled antibody (PAP) procedures. J Histochem
Cytochem 29:577–580, 1981
22. NADASDY T, LASZIK Z, BLICK KE, JOHNSON DL, BURST SINGER K,
NAST C, COHEN AH, ORMOS J, SILVA FG: Human acute tubular
necrosis: A lectin and immunohistochemical study. Hum Pathol
26:230–239, 1995
23. POLLOCK CA, FIELDS MJ: Compensatory renal hypertrophy: Tubular
cell growth and transport studied in primary culture. Nephron 64:615–
620, 1993
24. NOBES MS, POLLOCK CA, HENG PT, FIELD MJ: Modulators of growth
in primary culture of rat proximal tubular cells. Nephrol 1:65–72, 1995
25. WOOKEY PJ, CAO Z, VAN GEENEN RCI, VOSKUIL M, DARBY IA,
KOMERS R, COOPER ME: Increased density of renal amylin binding
sites in experimental hypertension. Hypertension 30:455–460, 1997
26. GROBSTEIN C: Inductive interaction in the development of the mouse
metanephros. J Exp Zool 130:319–340, 1955
27. GOSSENS CL, UNSWORTH BR: Evidence for a two-step mechanism
operating during in vitro mouse kidney tubulogenesis. J Embryol Exp
Morphol 28:615–631, 1972
28. SOROKIN L, EKBLOM P: Development of tubular and glomerular cells
of the kidney. Kidney Int 41:657–664, 1992
29. WOOLF AS, KOLASTI-JOANNOU M, HARDMAN P, ANDERMARCHER E,
MOORBY C, FINE LG, JAT PS, NOBLE MD, GHERARDI E: Roles of
hepatocyte growth factor/scatter factor and the Met receptor in early
development of the metanephros. J Cell Biol 128:171–184, 1995
30. BREIER G, ALBRECHT U, STERRER S, RISAU W: Expression of vascular
endothelial growth factor during embryonic angiogenesis and endo-
thelial cell differentiation. Development 114:521–532, 1992
31. SIMON M, GRONE HJ, JOHREN O, KULLMER J, PLATE KH, RISAU W,
FUCHS E: Expression of vascular endothelial growth factor and its
receptors in human renal ontogenesis and in adult kidney. Am J
Physiol 268:F240–F250, 1995
32. KAIPAINEN A, KORHONEN J, PAJUSOLA K, APRELIKOVA O, PERSICO M,
TERMAN B, ALITALO K: The related FLT4, FLT1, and KDR receptor
tyrosine kinases show distinct expression patterns in human fetal
endothelial cells. J Exp Med 178:2077–2088, 1993
33. OELRICHS RB, REID HH, BERNARD O, ZIEMIECKI A, WILKS AF:
NYK/FLK-1: A putative receptor protein tyrosine kinase isolated
from E10 embryonic neuroepithelium is expressed in endothelial cells
of the developing embryo. Oncogene 8:11–18, 1993
34. ROBERT B, ST JOHN PL, HYINK DP, ABRAHAMSON DR: Evidence that
embryonic kidney cells expressing FLK-1 are intrinsic, vasculogenic
angioblasts. Am J Physiol 40:F744–F753, 1996
35. EKBLOM P, MIETTINEN A, SAXEN L: Induction of brush border
antigens of the proximal tubule in the developing kidney. Develop Biol
74:263–274, 1980
36. HAMMERMAN MR: Growth factors in renal development. Semin
Nephrol 15:291–299, 1995
37. CANTLEY LG: Growth factors and the kidney: Regulation of epithelial
cell movement and morphogenesis. Am J Physiol 271:F1103–F1113,
1996
Wookey et al: Amylin as a renal growth factor30
